A vaccine against the Ebola virus has been developed and registered by Russia, president Vladimir Putin said.
In a meeting with cabinet ministers, he said, “We have registered a vaccine against Ebola that shows, after a series of tests, a very high effectiveness, even higher than the vaccines currently used for Ebola treatment in the world.”
Veronika Skvortsova, Russian Health Minister, said that two vaccines had been developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Academy of Medical Sciences. Applications were received from the two centers to test the vaccines.
“In December, Russia registered two Ebola fever vaccines, which were developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Academy of Medical Sciences and tested in cooperation with the Health and Defense ministries,” Skvortsova told Russian news agency Tass. “One of the vaccines is absolutely unique and has no analogues in the world. It provides 100 percent immunity to the disease.”
The documents for the vaccine had been registered and the testing was in its final stages in December, Anna Popova, the head of Russia’s consumer rights watchdog Rospotrebnadzor, said. Last month, Russian Deputy Prime Minister Olga Golodets said the vaccine had been tested successfully on people.
ABC News reports that other countries have also created Ebola vaccines. One such vaccine was developed by Merck, a U.S. company, which was tested in Guinea last year. It came up with effective results after it was tested on more than 4000 patients. The UK has also developed a vaccine against the Ebola virus.
The epidemic is to be declared over Thursday, The Guardian reports. It started in December 2013, with the outbreak spreading from Guinea to Liberia and Sierra Leone, having claimed 11,000 lives. As many as 28,000 people were infected by the disease.